VCYT — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

6.92

Margin Of Safety %

Put/Call OI Ratio

0.16

EPS Next Q Diff

-0.11

EPS Last/This Y

0.81

EPS This/Next Y

0.12

Price

32.16

Target Price

48.09

Analyst Recom

1.62

Performance Q

-26.31

Upside

-43.9%

Beta

2.02

Ticker: VCYT

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	VCYT	33.36	0.18	0.00	3597
2026-03-10	VCYT	32.74	0.16	6.00	3941
2026-03-11	VCYT	32.43	0.17	4.67	3968
2026-03-12	VCYT	30.96	0.17	0.50	3977
2026-03-13	VCYT	30.93	0.17	0.50	3977
2026-03-17	VCYT	33.51	0.16	0.00	3979
2026-03-18	VCYT	33.3	0.16	0.00	3981
2026-03-19	VCYT	32.77	0.16	1.60	3985
2026-03-20	VCYT	31.87	0.16	0.33	3978
2026-03-23	VCYT	33.5	0.18	0.00	2181
2026-03-24	VCYT	32.95	0.18	4.00	2183
2026-03-25	VCYT	32.79	0.19	0.00	2193
2026-03-26	VCYT	32.76	0.18	0.00	2186
2026-03-27	VCYT	30	0.18	0.00	2208
2026-03-30	VCYT	30.45	0.18	0.06	2209
2026-03-31	VCYT	32.2	0.15	0.00	2644
2026-04-01	VCYT	32.44	0.15	0.00	2695
2026-04-02	VCYT	32.24	0.15	3.00	2695
2026-04-06	VCYT	32.33	0.15	0.68	2694
2026-04-07	VCYT	32.12	0.16	0.00	2720
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	VCYT	33.33	7.5	34.2	1.65
2026-03-10	VCYT	32.76	7.5	34.0	1.65
2026-03-11	VCYT	32.44	7.5	34.8	1.65
2026-03-12	VCYT	30.92	7.5	30.3	1.65
2026-03-13	VCYT	32.15	7.5	40.8	1.65
2026-03-17	VCYT	33.50	7.5	38.1	1.65
2026-03-18	VCYT	33.32	7.5	35.5	1.65
2026-03-19	VCYT	32.78	7.5	9.3	1.65
2026-03-20	VCYT	31.84	7.5	8.2	1.65
2026-03-23	VCYT	33.52	7.5	15.6	1.65
2026-03-24	VCYT	32.95	7.5	9.1	1.65
2026-03-25	VCYT	32.78	7.5	10.3	1.65
2026-03-26	VCYT	32.78	7.5	10.8	1.65
2026-03-27	VCYT	29.99	7.5	2.9	1.65
2026-03-30	VCYT	30.44	7.5	12.2	1.65
2026-03-31	VCYT	32.19	6.9	16.3	1.65
2026-04-01	VCYT	32.40	6.9	11.3	1.65
2026-04-02	VCYT	32.22	6.9	10.3	1.65
2026-04-06	VCYT	32.31	6.9	11.0	1.65
2026-04-07	VCYT	32.16	6.9	10.4	1.65
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	VCYT	-13.66	-3.27	7.78
2026-03-10	VCYT	-13.66	-3.27	7.78
2026-03-11	VCYT	-13.66	-3.27	7.06
2026-03-12	VCYT	-13.66	-3.27	7.06
2026-03-13	VCYT	-13.66	-3.27	7.06
2026-03-17	VCYT	-13.66	-3.11	7.06
2026-03-18	VCYT	-13.66	-3.11	7.06
2026-03-19	VCYT	-13.66	-3.11	7.06
2026-03-20	VCYT	-13.66	-3.11	7.06
2026-03-23	VCYT	-13.66	-3.11	7.06
2026-03-24	VCYT	-13.56	-3.11	7.06
2026-03-25	VCYT	-13.56	-3.11	6.92
2026-03-26	VCYT	-13.56	-3.11	6.92
2026-03-27	VCYT	-13.56	-3.11	6.92
2026-03-30	VCYT	-13.56	-3.11	6.92
2026-03-31	VCYT	-13.56	-3.11	6.92
2026-04-01	VCYT	-13.56	-3.11	6.92
2026-04-02	VCYT	-13.56	-3.11	6.92
2026-04-06	VCYT	-12.41	-3.11	6.92
2026-04-07	VCYT	-12.41	-3.11	6.92
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.53

Avg. EPS Est. Current Quarter

0.33

Avg. EPS Est. Next Quarter

0.42

Insider Transactions

-12.41

Institutional Transactions

-3.11

Beta

2.02

Average Sales Estimate Current Quarter

130

Average Sales Estimate Next Quarter

143

Fair Value

32.89

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

46.3

Max Drawdown 5-Year %

-73

Target Price

48.09

P/E

39.15

Forward P/E

17.92

PEG

7.96

P/S

4.94

P/B

1.95

P/Free Cash Flow

20.17

EPS

0.82

Average EPS Est. Cur. Y

1.65

EPS Next Y. (Est.)

1.77

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

12.83

Relative Volume

0.54

Return on Equity vs Sector %

-22.4

Return on Equity vs Industry %

-5.7

EPS 1 7Days Diff

EPS 1 30Days Diff

0.12

EBIT Estimation

10.4

◆ VCYT Healthcare

$32.15

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

16/20

Pullback

15/25

Volume

11/15

Valuation

20/20

TP/AR

3/10

Options

6/10

RSI

44.3

Range 1M

54.9%

Sup Dist

0.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

14/30

Estimates

7/20

Inst/Vol

1/15

Options

7/10

EPS Yr

-6.8%

EPS NY

8.2%

52W%

33.6%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟡 HOLD +21.2% upside

Quality

13/30

Valuation

10/30

Growth

12/25

Stability

8/10

LT Trend

3/5

Upside

+21.2%

Quality

MoS

Veracyte, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 755

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

VCYT

Latest News

—

Caricamento notizie per VCYT…

stock quote shares VCYT – Veracyte, Inc. Stock Price stock today

news today VCYT – Veracyte, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch VCYT – Veracyte, Inc. yahoo finance google finance

stock history VCYT – Veracyte, Inc. invest stock market

stock prices VCYT premarket after hours

ticker VCYT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: VCYT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y